Dr. Elsa Zekeng is the founder and CEO of SökerData, a UK health data intelligence company tackling one of the most consequential gaps in modern medicine: the systematic under representation of women and global majority populations in clinical datasets. She holds a PhD in Infectious Diseases and Global Health, received a medal from Her Majesty Queen Elizabeth II for frontline Ebola response, and has published in Nature. SökerData, backed by Techstars London and Francis Crick KQ Labs, delivers bias detection and data quality auditing through its platform SökerScan, with active enterprise partnerships across Top 10 global pharmaceutical companies and national genomics institutions. Elsa’s work sits at the intersection of scientific rigour, regulatory change, and commercial necessity. Her argument is straightforward: representative data is not an ethical preference. It is the foundation on which safe, effective, and equitable medicine must be built.
In partnership with
